AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. AIM
  4. [EFFECT] AIM ImmunoTech Inc. SEC Filing

[EFFECT] AIM ImmunoTech Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
Rhea-AI Filing Summary
Riscrivi il testo seguente:
Reescribe el siguiente texto:
雼れ潓 韰嶌姢韸鸽ゼ 雼れ嫓 鞛戩劚頃橃劯鞖�:
R茅茅crivez le texte suivant :
Schreibe den folgenden Text um:
Positive
  • None.
Negative
  • None.
Riscrivi il testo seguente:
Reescribe el siguiente texto:
雼れ潓 韰嶌姢韸鸽ゼ 雼れ嫓 鞛戩劚頃橃劯鞖�:
R茅茅crivez le texte suivant :
Schreibe den folgenden Text um:
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 3, 2025 4:00 P.M.
Form: S-3
CIK: 0000946644
Company Name: AIM ImmunoTech Inc.
File Number: 333-286319

Source:

Stock AIM logo
Aim Immunotech

NYSE:AIM

AIM Rankings

#11331 Ranked by Market Cap
N/A Ranked by Dividends

AIM Latest News

Aug 4, 2025
AIM ImmunoTech Builds Positive Momentum and Reiterates Focus on Driving Ampligen庐 Clinical Development Toward Pancreatic Cancer Approval
Jul 31, 2025
AIM ImmunoTech Announces Closing of $8.0 Million Public Offering
Jul 29, 2025
AIM ImmunoTech Announces Pricing of $8.0 Million Public Offering
Jul 28, 2025
AIM ImmunoTech Reports Positive Mid-year Safety and Efficacy Data from Phase 2 Study Evaluating Ampligen庐 (rintatolimod) in Combination with AstraZeneca鈥檚 Imfinzi庐 (durvalumab) for the Treatment of Pancreatic Cancer
Jul 2, 2025
AIM ImmunoTech Announces Recent Presentation on the Potential of Private-Public Partnerships for the Development of Oncology Therapies

AIM Latest SEC Filings

Jul 31, 2025
[8-K] AIM ImmunoTech Inc. Reports Material Event
Jul 30, 2025
[424B5] AIM ImmunoTech Inc. Prospectus Supplement (Debt Securities)
Jul 28, 2025
[8-K] AIM ImmunoTech Inc. Reports Material Event
Jul 22, 2025
[S-1/A] AIM ImmunoTech Inc. Amends IPO Registration Statement
Jul 21, 2025
[Form 4] AIM ImmunoTech Inc. Insider Trading Activity

AIM Stock Data

2.16M
2.67M
3.35%
2.94%
1.07%
Biotechnology
Biological Products, (no Disgnostic Substances)
United States
OCALA